Viveca Gyberg

2.4k total citations
23 papers, 363 citations indexed

About

Viveca Gyberg is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Viveca Gyberg has authored 23 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Viveca Gyberg's work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Diabetes Treatment and Management (7 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers). Viveca Gyberg is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Diabetes Treatment and Management (7 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers). Viveca Gyberg collaborates with scholars based in Sweden, United Kingdom and Finland. Viveca Gyberg's co-authors include Lars Rydén, David Wood, Kornelia Kotseva, Guy De Backer, Dirk De Bacquer, Linda Mellbin, Oliver Schnell, Jaakko Tuomilehto, Bahira Shahim and Catriona Jennings and has published in prestigious journals such as Journal of the American College of Cardiology, Diabetes Care and European Heart Journal.

In The Last Decade

Viveca Gyberg

23 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viveca Gyberg Sweden 10 182 166 70 62 47 23 363
Marit de Jong Netherlands 8 203 1.1× 129 0.8× 47 0.7× 53 0.9× 43 0.9× 9 359
Margaret Tiktin United States 6 336 1.8× 80 0.5× 86 1.2× 64 1.0× 49 1.0× 7 480
Sergio Jansen‐Chaparro Spain 9 179 1.0× 49 0.3× 42 0.6× 55 0.9× 33 0.7× 13 332
Xiaojun Luan China 8 204 1.1× 79 0.5× 73 1.0× 86 1.4× 42 0.9× 11 343
Ricardo García‐Sánchez United States 10 242 1.3× 49 0.3× 89 1.3× 68 1.1× 68 1.4× 14 331
Michael Colacci Canada 10 89 0.5× 122 0.7× 37 0.5× 47 0.8× 43 0.9× 25 315
Frederick Berro Rivera United States 9 111 0.6× 99 0.6× 43 0.6× 67 1.1× 27 0.6× 38 286
Margarida Borges Portugal 6 150 0.8× 50 0.3× 22 0.3× 136 2.2× 32 0.7× 8 282
Ole Molskov Bech Denmark 10 247 1.4× 31 0.2× 82 1.2× 57 0.9× 29 0.6× 16 402
Amrita M. Karve United States 5 89 0.5× 69 0.4× 34 0.5× 49 0.8× 22 0.5× 7 311

Countries citing papers authored by Viveca Gyberg

Since Specialization
Citations

This map shows the geographic impact of Viveca Gyberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viveca Gyberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viveca Gyberg more than expected).

Fields of papers citing papers by Viveca Gyberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viveca Gyberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viveca Gyberg. The network helps show where Viveca Gyberg may publish in the future.

Co-authorship network of co-authors of Viveca Gyberg

This figure shows the co-authorship network connecting the top 25 collaborators of Viveca Gyberg. A scholar is included among the top collaborators of Viveca Gyberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viveca Gyberg. Viveca Gyberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winters, Maike, et al.. (2025). Navigating information space: the role of health-care providers in the health-information journey of patients. 1(3). 100040–100040. 2 indexed citations
2.
Ferrannini, Giulia, Mette Bjerre, Troels Krarup Hansen, et al.. (2022). Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort. Cardiovascular Diabetology. 21(1). 129–129. 1 indexed citations
3.
Ferrannini, Giulia, Dirk De Bacquer, Viveca Gyberg, et al.. (2021). Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test. Diabetes Research and Clinical Practice. 183. 109156–109156. 4 indexed citations
4.
5.
Ferrannini, Giulia, et al.. (2020). Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management. Diabetes Care. 43(9). 2001–2009. 16 indexed citations
6.
7.
Shahim, Bahira, Barbro Kjellström, Viveca Gyberg, et al.. (2018). The Accuracy of Point-of-Care Equipment for Glucose Measurement in Screening for Dysglycemia in Patients with Coronary Artery Disease. Diabetes Technology & Therapeutics. 20(9). 596–602. 8 indexed citations
8.
Arver, Stefan, John N. Flanagan, Viveca Gyberg, et al.. (2018). Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction. Diabetes and Vascular Disease Research. 15(6). 511–518. 2 indexed citations
9.
Shahim, Bahira, Dirk De Bacquer, Guy De Backer, et al.. (2017). The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV. Diabetes Care. 40(9). 1233–1240. 68 indexed citations
10.
11.
Gyberg, Viveca, Dirk De Bacquer, Kornelia Kotseva, et al.. (2016). Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV. BMJ Open. 6(12). e013835–e013835. 5 indexed citations
12.
Kotseva, Kornelia, Dirk De Bacquer, Guy De Backer, et al.. (2016). ACHIEVEMENT OF LIFESTYLE, BLOOD PRESSURE, LIPIDS AND DIABETES GOALS FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE ACROSS EUROPE: RESULTS OF EUROASPIRE IV SURVEY. Journal of the American College of Cardiology. 67(13). 1976–1976. 1 indexed citations
13.
Kotseva, Kornelia, Dirk De Bacquer, Guy De Backer, et al.. (2016). PT082 Lifestyle Profiles of Patients at High Risk of Developing CVD in the EUROASPIRE IV Survey of CVD Prevention and Diabetes From 14 European Regions. Global Heart. 11(2). e140–e140. 1 indexed citations
14.
Kotseva, Kornelia, Dirk De Bacquer, Catriona Jennings, et al.. (2016). Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999–2013. Global Heart. 12(4). 315–315. 82 indexed citations
15.
Gyberg, Viveca, et al.. (2015). Accuracy of a Simplified Glucose Measurement Device—The HemoCue Glucose 201RT. Diabetes Technology & Therapeutics. 17(10). 755–758. 12 indexed citations
16.
17.
Kotseva, Kornelia, Catriona Jennings, Dirk De Bacquer, et al.. (2015). 149 Lifestyle, Blood Pressure, Lipids and Diabetes Management in Patients with Coronary Heart Disease From 24 Countries in Europe. A86.1–A86. 1 indexed citations
18.
Kotseva, Kornelia, Dirk De Bacquer, Catriona Jennings, et al.. (2014). TIME TRENDS IN CARDIOVASCULAR RISK FACTOR MANAGEMENT IN CORONARY PATIENTS IN EUROPE: RESULTS FROM THREE EUROASPIRE SURVEYS 1999-2013. Journal of the American College of Cardiology. 63(12). A1295–A1295. 1 indexed citations
19.
Gyberg, Viveca, Kornelia Kotseva, Jean Dallongeville, et al.. (2014). Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study. European Journal of Preventive Cardiology. 22(6). 753–761. 22 indexed citations
20.
Gyberg, Viveca, Dan Hasson, Jaakko Tuomilehto, & Lars Rydén. (2012). Measuring risk online—Feasibility of using FINDRISC in an online workplace survey. Primary care diabetes. 6(2). 103–107. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marit de Jong Breakdown of academic impact, for papers by Margaret Tiktin Breakdown of academic impact, for papers by Sergio Jansen‐Chaparro Breakdown of academic impact, for papers by Xiaojun Luan Breakdown of academic impact, for papers by Ricardo García‐Sánchez Breakdown of academic impact, for papers by Michael Colacci Breakdown of academic impact, for papers by Frederick Berro Rivera Breakdown of academic impact, for papers by Margarida Borges Breakdown of academic impact, for papers by Ole Molskov Bech Breakdown of academic impact, for papers by Amrita M. Karve
Rankless by CCL
2026